<i<Physalis peruviana</i<-Derived Physapruin A (PHA) Inhibits Breast Cancer Cell Proliferation and Induces Oxidative-Stress-Mediated Apoptosis and DNA Damage
Breast cancer expresses clinically heterogeneous characteristics and requires multipurpose drug development for curing the different tumor subtypes. Many withanolides have been isolated from <i<Physalis</i< species showing anticancer effects, but the anticancer function of physapruin A (PHA) has rarely been investigated. In this study, the anticancer properties of PHA in breast cancer cells were examined by concentration and time-course experiments. In terms of cellular ATP content, PHA inhibited the proliferation of three kinds of breast cancer cells: MCF7 (estrogen receptor (ER)+, progesterone receptor (PR)+/−, human epidermal growth factor receptor 2 (HER2)−), SKBR3 (ER−/PR−/HER2+), and MDA-MB-231 (triple-negative). Moreover, PHA induced G2/M arrest in MCF7 and MDA-MB-231 cells. In terms of flow cytometry, PHA induced the generation of reactive oxygen species (ROS), the generation of mitochondrial superoxide, mitochondrial membrane potential depletion, and γH2AX-detected DNA damage in breast cancer MCF7 and MDA-MB-231 cells, which were suppressed by the ROS inhibitor <i<N</i<-acetylcysteine (NAC). In terms of flow cytometry and Western blotting, PHA induced apoptotic expression (annexin V, and intrinsic and extrinsic apoptotic signaling), which was suppressed by NAC and an apoptosis inhibitor (Z-VAD-FMK), in breast cancer cells. Therefore, PHA is a potential anti-breast-cancer natural product that modulates the oxidative-stress response, cell-cycle disturbance, apoptosis, and γH2AX-detected DNA damage..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Antioxidants - 10(2021), 3, p 393 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tzu-Jung Yu [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
Apoptosis |
---|
doi: |
10.3390/antiox10030393 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ068154569 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ068154569 | ||
003 | DE-627 | ||
005 | 20240414081852.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230228s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/antiox10030393 |2 doi | |
035 | |a (DE-627)DOAJ068154569 | ||
035 | |a (DE-599)DOAJb6278ed64fa34f9fa1312a44beae70d8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a RM1-950 | |
100 | 0 | |a Tzu-Jung Yu |e verfasserin |4 aut | |
245 | 1 | 0 | |a <i<Physalis peruviana</i<-Derived Physapruin A (PHA) Inhibits Breast Cancer Cell Proliferation and Induces Oxidative-Stress-Mediated Apoptosis and DNA Damage |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Breast cancer expresses clinically heterogeneous characteristics and requires multipurpose drug development for curing the different tumor subtypes. Many withanolides have been isolated from <i<Physalis</i< species showing anticancer effects, but the anticancer function of physapruin A (PHA) has rarely been investigated. In this study, the anticancer properties of PHA in breast cancer cells were examined by concentration and time-course experiments. In terms of cellular ATP content, PHA inhibited the proliferation of three kinds of breast cancer cells: MCF7 (estrogen receptor (ER)+, progesterone receptor (PR)+/−, human epidermal growth factor receptor 2 (HER2)−), SKBR3 (ER−/PR−/HER2+), and MDA-MB-231 (triple-negative). Moreover, PHA induced G2/M arrest in MCF7 and MDA-MB-231 cells. In terms of flow cytometry, PHA induced the generation of reactive oxygen species (ROS), the generation of mitochondrial superoxide, mitochondrial membrane potential depletion, and γH2AX-detected DNA damage in breast cancer MCF7 and MDA-MB-231 cells, which were suppressed by the ROS inhibitor <i<N</i<-acetylcysteine (NAC). In terms of flow cytometry and Western blotting, PHA induced apoptotic expression (annexin V, and intrinsic and extrinsic apoptotic signaling), which was suppressed by NAC and an apoptosis inhibitor (Z-VAD-FMK), in breast cancer cells. Therefore, PHA is a potential anti-breast-cancer natural product that modulates the oxidative-stress response, cell-cycle disturbance, apoptosis, and γH2AX-detected DNA damage. | ||
650 | 4 | |a withanolide | |
650 | 4 | |a breast cancer | |
650 | 4 | |a apoptosis | |
650 | 4 | |a oxidative stress | |
650 | 4 | |a DNA damage | |
653 | 0 | |a Therapeutics. Pharmacology | |
700 | 0 | |a Yuan-Bin Cheng |e verfasserin |4 aut | |
700 | 0 | |a Li-Ching Lin |e verfasserin |4 aut | |
700 | 0 | |a Yi-Hong Tsai |e verfasserin |4 aut | |
700 | 0 | |a Bo-Yi Yao |e verfasserin |4 aut | |
700 | 0 | |a Jen-Yang Tang |e verfasserin |4 aut | |
700 | 0 | |a Fang-Rong Chang |e verfasserin |4 aut | |
700 | 0 | |a Chia-Hung Yen |e verfasserin |4 aut | |
700 | 0 | |a Fu Ou-Yang |e verfasserin |4 aut | |
700 | 0 | |a Hsueh-Wei Chang |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Antioxidants |d MDPI AG, 2013 |g 10(2021), 3, p 393 |w (DE-627)DOAJ000099481 |x 20763921 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2021 |g number:3, p 393 |
856 | 4 | 0 | |u https://doi.org/10.3390/antiox10030393 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/b6278ed64fa34f9fa1312a44beae70d8 |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/2076-3921/10/3/393 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2076-3921 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
951 | |a AR | ||
952 | |d 10 |j 2021 |e 3, p 393 |